Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER…
Kamal Pandey
Journal Club
0
3339
2019.08.27 11:28
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
Luigi et al, Nat Commun. 2019; 10(1):1373.
Luigi et al, Nat Commun. 2019; 10(1):1373.
